ANXA6 and neoplasm: In a typical TNBC tumor, the probability for co-expression of AnxA6 and vimentin is higher than with Ki67 or between AnxA6 and Ki67 (Figure 1J) and supports the use of vimentin and AnxA6 as bona fide markers of invasiveness.